A detailed history of Rothschild Investment LLC transactions in Mannkind Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 260 shares of MNKD stock, worth $1,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares
260
Previous 90 188.89%
Holding current value
$1,921
Previous $470,000 247.87%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$5.01 - $6.7 $851 - $1,139
170 Added 188.89%
260 $1.64 Million
Q2 2024

Jul 30, 2024

BUY
$4.05 - $5.43 $364 - $488
90 New
90 $470,000
Q1 2024

Jul 31, 2024

SELL
$3.25 - $5.27 $211 - $342
-65 Reduced 72.22%
25 $113,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.9B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.